Bluejay Diagnostics (BJDX) Other Accumulated Expenses (2020 - 2026)

Bluejay Diagnostics has disclosed Other Accumulated Expenses across 6 years of filings, most recently posting $104829.0 for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $104829.0, up 0.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $104829.0 (up 0.61% YoY), and the FY2025 annual result was $156567.0, up 35.58% from the prior year.
• Other Accumulated Expenses came in at $104829.0 for Q1 2026 at Bluejay Diagnostics, down from $156567.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $231635.0 in Q3 2024 to a low of $104194.0 in Q1 2025.
• The 4-year median for Other Accumulated Expenses is $156567.0 (2025), against an average of $154209.1.
• Across the five-year window, Other Accumulated Expenses decreased 25.29% in 2024 and soared 35.58% in 2025, its largest moves.
• Bluejay Diagnostics' Other Accumulated Expenses stood at $154575.0 in 2023, then fell by 25.29% to $115479.0 in 2024, then surged by 35.58% to $156567.0 in 2025, then slumped by 33.05% to $104829.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $104829.0 (Q1 2026), $156567.0 (Q4 2025), and $189088.0 (Q3 2025), per Business Quant data.